Diseases, Conditions, Syndromes

Subcirrhotic liver stiffness cuts HCC risk in hepatitis B

(HealthDay)—For patients with chronic hepatitis B (CHB), achievement of subcirrhotic range of liver stiffness (sc-LS) with antiviral therapy (AVT) is associated with reduced risk of hepatocellular carcinoma (HCC), according ...

Diseases, Conditions, Syndromes

Tenofovir disoproxil fumarate can cut HBV transmission

(HealthDay)—Use of tenofovir disoproxil fumarate (TDF) during pregnancy can reduce the rate of mother-to-child transmission of hepatitis B virus (HBV), according to a study published in the June 16 issue of the New England ...

Medical research

FDA-approved drug protects mice from Ebola

The recent Ebola outbreak in West Africa has claimed more than 11,300 lives and starkly revealed the lack of effective options for treating or preventing the disease. Progress has been made on developing vaccines, but there ...

Medical research

Familiar drugs may block Ebola virus infection

A well-known class of molecules, many of which are already in use therapeutically, may be able to block the Ebola virus's entry into cells and halt the disease in its tracks, according to researchers at the University of ...

HIV & AIDS

New model to study HIV latency in brain cells

Over 35 million people worldwide are currently infected by HIV. Antiviral therapies can keep the virus from multiplying. However, no drug can cure infection so far, because various cell types continue to carry the virus in ...

Diseases, Conditions, Syndromes

Statin use found beneficial in hepatitis C treatment

(HealthDay)—For patients with hepatitis C virus (HCV), statin therapy is associated with improved virologic response rates, as well as decreased liver fibrosis progression and hepatocellular carcinoma (HCC) incidence, according ...

page 5 from 11